Trade LPCN stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Lipocine Inc. (LPCN) is trading at US$2.15, down 4.11% today as of Sep 22, 12:37 EDT. The company has a market capitalisation of US$17.23M. Over the past 52 weeks, LPCN has traded between US$1.81 and US$12.37. On Syfe you can trade LPCN with $0 commission and add it to your watchlist.
| Previous close | US$2.24 |
|---|---|
| Market cap | US$17.23M |
| 52-week range | US$1.81 – US$12.37 |
| Volume | 16.7K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Lipocine Inc.
Lipocine, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of the delivery of drugs using proprietary delivery technology. It offers TLANDO, an oral testosterone replacement therapy. The company was founded on October 13, 2011 and is headquartered in Salt Lake City, UT.
Year: 2012
--HC Wainwright Downgrades Lipocine to Neutral From Buy
Apr 6, 11:29 AM · MT Newswires
Lipocine Says Phase 3 Postpartum Depression Study Misses Primary Endpoint
Apr 2, 12:49 PM · MT Newswires
Lipocine Inc. (LPCN) stock is trading at US$2.15, -4.11% from the previous close of US$2.24.
The market cap for Lipocine Inc. (LPCN) stock is approximately US$17.23M.
The 52-week high for Lipocine Inc. (LPCN) stock is US$12.37.
The 52-week low for Lipocine Inc. (LPCN) stock is US$1.81.
Lipocine Inc. (LPCN) does not currently pay a dividend.
Stay on top of LPCN
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
